Prokidney (PROK) Accumulated Depreciation (2021 - 2025)
Prokidney's (PROK) quarterly Accumulated Depreciation came in at $16.6 million in Q4 2025, up 50.04% year-on-year from $11.0 million in Q4 2024, and up 19.24% on a QoQ basis from $13.9 million in Q2 2025.
Prokidney (PROK) Accumulated Depreciation (2021 - 2025) Analysis & Trends
Prokidney (PROK) has 5 years of Accumulated Depreciation data on file, last reported at $16.6 million in Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 50.04% year-over-year to $16.6 million in Q4 2025; TTM through Dec 2025 was $16.6 million, a 50.04% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, up 50.04% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $16.6 million, up from $13.9 million in the prior quarter.
- Over the last five years, Accumulated Depreciation for PROK reached as high as $16.6 million in Q4 2025 and fell as low as $2.3 million in Q4 2021.
- Historically, Accumulated Depreciation has averaged $8.5 million across 5 years, with a median of $8.0 million in 2023.
- Across the five-year window, Accumulated Depreciation jumped 108.41% in 2022 and soared 44.36% in 2024, its largest moves.
- Year by year, Accumulated Depreciation stood at $2.3 million in 2021, then jumped by 108.41% to $4.7 million in 2022, then jumped by 62.32% to $7.6 million in 2023, then jumped by 44.36% to $11.0 million in 2024, then jumped by 50.04% to $16.6 million in 2025.
- Per Business Quant data, the three most recent Accumulated Depreciation figures were $16.6 million in Q4 2025, $13.9 million in Q2 2025, and $12.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.55 Mn |
| Jun 30, 2025 | 13.88 Mn |
| Mar 31, 2025 | 12.41 Mn |
| Dec 31, 2024 | 11.03 Mn |
| Sep 30, 2024 | 10.57 Mn |
| Jun 30, 2024 | 9.40 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 7.64 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 5.98 Mn |
| Mar 31, 2023 | 5.33 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | 4.09 Mn |
| Dec 31, 2021 | 2.26 Mn |